株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

Enceladus Pharmaceuticals BVの製品パイプライン分析

Enceladus Pharmaceuticals BV - Product Pipeline Review - 2015

発行 Global Markets Direct 商品コード 321972
出版日 ページ情報 英文 23 Pages
即納可能
価格
本日の銀行送金レート: 1USD=115.27円で換算しております。

2016年12月31日まで 年末キャンペーン割引: Global Markets Direct社発行レポート
ご注意: ショッピングカートでは適用されませんので、割引価格についてはお問い合わせください

Back to Top
Enceladus Pharmaceuticals BVの製品パイプライン分析 Enceladus Pharmaceuticals BV - Product Pipeline Review - 2015
出版日: 2015年05月13日 ページ情報: 英文 23 Pages
概要

Enceladus Pharmaceuticals BVはオランダに本社を置く創薬企業で、癌、炎症、自己免疫疾患治療用のコルチコステロイド含有リポソーム製剤の開発を行っています。

当レポートでは、Enceladus Pharmaceuticals BVにおける治療薬開発パイプラインの現況と各開発段階の比較分析、薬剤標的、作用機序、投与経路、分子タイプ別の治療薬の評価、最新の企業ニュースや発表、後期段階および中止されたプロジェクトに関する情報などを提供しています。

目次

Enceladus Pharmaceuticals BVの基本情報

  • Enceladus Pharmaceuticals BVの概要
  • 主要情報
  • 企業情報

Enceladus Pharmaceuticals BV:R&Dの概要

  • 主な治療範囲

Enceladus Pharmaceuticals BV:パイプラインのレビュー

  • 開発段階別のパイプライン製品
  • 単剤製品

Enceladus Pharmaceuticals BV:パイプライン製品の概況

  • 臨床段階にあるパイプライン製品
    • 第2相の製品/併用療法モダリティ
    • 第1相の製品/併用療法モダリティ
  • 初期段階にあるパイプライン製品
    • 前臨床段階の製品/併用療法モダリティ
    • 創薬段階の製品/併用療法モダリティ

Enceladus Pharmaceuticals BV:薬剤プロファイル

  • Nanocort
  • dexamethasone acetate
  • Liposomal corticosteroid

Enceladus Pharmaceuticals BV:パイプライン分析

  • 標的別
  • 投与経路別
  • 分子タイプ別
  • 作用機序別

Enceladus Pharmaceuticals BV:開発休止中のプロジェクト

Enceladus Pharmaceuticals BV:本社と子会社の所在地

  • 本社

付録

図表一覧

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: GMDHC07085CDB

Summary

Global Markets Direct's, 'Enceladus Pharmaceuticals BV - Product Pipeline Review - 2015', provides an overview of the Enceladus Pharmaceuticals BV's pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Enceladus Pharmaceuticals BV's, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides brief overview of Enceladus Pharmaceuticals BV including business description, key information and facts, and its locations and subsidiaries
  • The report reviews current pipeline of Enceladus Pharmaceuticals BV's human therapeutic division and enlists all their major and minor projects
  • The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones
  • Special feature on out-licensed and partnered product portfolio
  • The report summarizes all the dormant and discontinued pipeline projects
  • Latest company statement
  • Latest news and deals relating to the Enceladus Pharmaceuticals BV's pipeline products

Reasons to buy

  • Evaluate Enceladus Pharmaceuticals BV's strategic position with total access to detailed information on its product pipeline
  • Assess the growth potential of Enceladus Pharmaceuticals BV in its therapy areas of focus
  • Identify new drug targets and therapeutic classes in the Enceladus Pharmaceuticals BV's R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
  • Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
  • Develop strategic initiatives by understanding the focus areas of Enceladus Pharmaceuticals BV and exploit collaboration and partnership opportunities
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Plan mergers and acquisitions effectively by identifying the most promising pipeline of Enceladus Pharmaceuticals BV
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
  • Explore the dormant and discontinued projects of Enceladus Pharmaceuticals BV and identify potential opportunities in those areas
  • Avoid Intellectual Property Rights related issues

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Enceladus Pharmaceuticals BV Snapshot
    • Enceladus Pharmaceuticals BV Overview
    • Key Information
    • Key Facts
  • Enceladus Pharmaceuticals BV - Research and Development Overview
    • Key Therapeutic Areas
  • Enceladus Pharmaceuticals BV - Pipeline Review
    • Pipeline Products by Stage of Development
    • Pipeline Products - Monotherapy
  • Enceladus Pharmaceuticals BV - Pipeline Products Glance
    • Enceladus Pharmaceuticals BV - Clinical Stage Pipeline Products
      • Phase II Products/Combination Treatment Modalities
      • Phase I Products/Combination Treatment Modalities
    • Enceladus Pharmaceuticals BV - Early Stage Pipeline Products
      • Preclinical Products/Combination Treatment Modalities
      • Discovery Products/Combination Treatment Modalities
  • Enceladus Pharmaceuticals BV - Drug Profiles
    • prednisolone sodium phosphate liposomal
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • dexamethasone acetate liposomal
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Corticosteroid liposimal
      • Product Description
      • Mechanism of Action
      • R&D Progress
  • Enceladus Pharmaceuticals BV - Pipeline Analysis
  • Enceladus Pharmaceuticals BV - Pipeline Products by Target
  • Enceladus Pharmaceuticals BV - Pipeline Products by Route of Administration
  • Enceladus Pharmaceuticals BV - Pipeline Products by Molecule Type
  • Enceladus Pharmaceuticals BV - Pipeline Products by Mechanism of Action
  • Enceladus Pharmaceuticals BV - Locations And Subsidiaries
    • Head Office
  • Appendix
    • Methodology
    • Coverage
    • Secondary Research
    • Primary Research
    • Expert Panel Validation
    • Contact Us
    • Disclaimer

List of Tables

  • Enceladus Pharmaceuticals BV, Key Information
  • Enceladus Pharmaceuticals BV, Key Facts
  • Enceladus Pharmaceuticals BV - Pipeline by Indication, 2015
  • Enceladus Pharmaceuticals BV - Pipeline by Stage of Development, 2015
  • Enceladus Pharmaceuticals BV - Monotherapy Products in Pipeline, 2015
  • Enceladus Pharmaceuticals BV - Phase II, 2015
  • Enceladus Pharmaceuticals BV - Phase I, 2015
  • Enceladus Pharmaceuticals BV - Preclinical, 2015
  • Enceladus Pharmaceuticals BV - Discovery, 2015
  • Enceladus Pharmaceuticals BV - Pipeline by Target, 2015
  • Enceladus Pharmaceuticals BV - Pipeline by Route of Administration, 2015
  • Enceladus Pharmaceuticals BV - Pipeline by Molecule Type, 2015
  • Enceladus Pharmaceuticals BV - Pipeline Products by Mechanism of Action, 2015

List of Figures

  • Enceladus Pharmaceuticals BV - Pipeline by Top 10 Indication, 2015
  • Enceladus Pharmaceuticals BV - Pipeline by Stage of Development, 2015
  • Enceladus Pharmaceuticals BV - Monotherapy Products in Pipeline, 2015
  • Enceladus Pharmaceuticals BV - Pipeline by Top 10 Target, 2015
  • Enceladus Pharmaceuticals BV - Pipeline by Top 10 Route of Administration, 2015
  • Enceladus Pharmaceuticals BV - Pipeline by Top 10 Molecule Type, 2015
  • Enceladus Pharmaceuticals BV - Pipeline Products by Top 10 Mechanism of Action, 2015
Back to Top